APA (7th ed.) Citation

Falkson, C. I., & Cohen, G. (1998). Mitomycin C, Epirubicin and Cisplatin versus Mitomycin C Alone as Therapy for Carcinoma of Unknown Primary Origin. Oncology, 55(2), 116-121. https://doi.org/10.1159/000011845

Chicago Style (17th ed.) Citation

Falkson, Carla I., and G.L Cohen. "Mitomycin C, Epirubicin and Cisplatin Versus Mitomycin C Alone as Therapy for Carcinoma of Unknown Primary Origin." Oncology 55, no. 2 (1998): 116-121. https://doi.org/10.1159/000011845.

MLA (9th ed.) Citation

Falkson, Carla I., and G.L Cohen. "Mitomycin C, Epirubicin and Cisplatin Versus Mitomycin C Alone as Therapy for Carcinoma of Unknown Primary Origin." Oncology, vol. 55, no. 2, 1998, pp. 116-121, https://doi.org/10.1159/000011845.